| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T11 |
0-12 |
CI |
denotes |
Upadacitinib |
| T1 |
34-81 |
DP |
denotes |
active non-radiographic axial spondyloarthritis |
| T25 |
127-134 |
CI |
denotes |
placebo |
| T12 |
174-186 |
CI |
denotes |
Upadacitinib |
| T14 |
332-344 |
CI |
denotes |
upadacitinib |
| T5 |
348-388 |
DP |
denotes |
non-radiographic axial spondyloarthritis |
| T7 |
417-457 |
DP |
denotes |
non-radiographic axial spondyloarthritis |
| T26 |
509-516 |
CI |
denotes |
placebo |
| T2 |
811-858 |
DP |
denotes |
active non-radiographic axial spondyloarthritis |
| T15 |
1064-1076 |
CI |
denotes |
upadacitinib |
| T27 |
1097-1104 |
CI |
denotes |
placebo |
| T3 |
2042-2089 |
DP |
denotes |
active non-radiographic axial spondyloarthritis |
| T16 |
2160-2172 |
CI |
denotes |
upadacitinib |
| T28 |
2194-2201 |
CI |
denotes |
placebo |
| T17 |
2241-2253 |
CI |
denotes |
upadacitinib |
| T29 |
2275-2282 |
CI |
denotes |
placebo |
| T18 |
2394-2406 |
CI |
denotes |
upadacitinib |
| T30 |
2421-2428 |
CI |
denotes |
placebo |
| T19 |
2606-2618 |
CI |
denotes |
upadacitinib |
| T31 |
2656-2663 |
CI |
denotes |
placebo |
| T20 |
2826-2838 |
CI |
denotes |
upadacitinib |
| T32 |
2881-2888 |
CI |
denotes |
placebo |
| T21 |
3031-3043 |
CI |
denotes |
upadacitinib |
| T33 |
3086-3093 |
CI |
denotes |
placebo |
| T22 |
3135-3147 |
CI |
denotes |
upadacitinib |
| T34 |
3212-3219 |
CI |
denotes |
placebo |
| T23 |
3366-3378 |
CI |
denotes |
upadacitinib |
| T13 |
3406-3418 |
CI |
denotes |
Upadacitinib |
| T10 |
3468-3508 |
DP |
denotes |
non-radiographic axial spondyloarthritis |
| T35 |
3523-3530 |
CI |
denotes |
placebo |
| T24 |
3583-3595 |
CI |
denotes |
upadacitinib |
| T4 |
3641-3688 |
DP |
denotes |
active non-radiographic axial spondyloarthritis |
